Enhancing violacein production in an Antarctic bacterial strain: New opportunities for biomedical use
Year: 2026
Type: preprint
Abstract: Violacein is a valuable bioactive metabolite produced by diverse bacteria, including the Antarctic isolate Janthinobacterium sp. UV13. Despite its broad therapeutic potential, large-scale production in native producers is hindered by low yields and the concurrent synthesis of exopolysaccharides, which increases downstream processing complexity and costs. This study employed a sequential statistical approach to optimize culture parameters, enhancing violacein productivity while minimizing exopolysaccharides production in UV13. The methodology included carbon and nitrogen source screening, a Plackett–Burman design and a concentration–response optimization, followed by chemical inducers evaluation. Results demonstrated that sucrose was an effective carbon source (violacein yield: 32.75 ± 1.07 mg/L). Inorganic nitrogen significantly favored violacein synthesis (yield: 26 - 28 mg/L, p < 0.05) over organic alternatives which reduced violacein yields 3.4- to 4.2-fold. A single-factor central composite design of ammonium sulfate concentration yielded a formulation producing 75.8 mg/L of violacein with an exopolysaccharide titer of 0.91 mg/L. Furthermore, tryptophan was the better inducer, increasing violacein production 2.2-fold ( p < 0.05) while simultaneously decreasing exopolysaccharides formation 4.5-fold. The new formulated medium significantly outperformed previously reported conditions, demonstrating that parameter manipulation unlocks UV13’s biosynthetic potential for scalable violacein production.
Language: English
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7235251574
